#IOLCP

IOL Chemicals & Pharmaceuticals posts a key update ⚡ #IOLCP

#IOLCP 7% up 🚀🚀 202.5+ Stop Loss Moved to Breakeven Here's my Link of Entry Position posted real time & Not End of Day (EOD)

#NEWPOSITION Long in #IOLCP at 177 SL : Pivot Low Note : Not a Buy/Sell Recommendation

#IOLCP - A multibagger in the making ❤️ CMP 460 Target 4500-5000

#Watchlist for Monday 🥸 Disclaimer 🚨 Not a Buy Sell recommendation. Don't try to copy me you can loose all your money 💰. 1. #iolcp

#IOLCP IOL Chemicals & Pharmaceuticals Ltd | Q2FY27 Earnings Concall Takeaways | Full Call Intelligence on Stocksigma Concall Monitor

🔘OCTOBER 2026🔘 🔸Monthly Breakout Stocks🔸 💠Coforge Ltd 💠Hitech Corporation Ltd 💠Indian Hotels Co Ltd 💠IOL Chemicals & Pharmaceuticals Ltd 💠Kotak Mahindra Bank Ltd 💠PVR Inox Ltd 💠Sona BLW Precision Forgings Ltd 💠Tips Music Ltd Disclaimer: Education only, No buy/sell recommendations.

3) INDHOTEL Breakout soon🔥🔥 #indhotel

4) IOLCP #IOLCP

Some promising setups I'm keeping an eye on for the upcoming week. #IOLCP

#IOLCP - I didn't expect so mute reaction today. Any explanations?🤔

Most crowded stock for next week Awards goes To : #IOLCP & #SOTL 🙂‍↕️

🔥Stocks Im Tracking for tomorrow My fav 1, 3, 5 & 6 Save it for Later🔖 01. #IOLCP

#iolcp When it was at 19 years of support retesting it was shouting for accumulation at 57. The first target should be red resistance line where a pullback should appear Thats y any stock retesting on long term trendline are key focus area.

Updated chart!!! Price is unable to close above the breakout zone, which means we still remain in Wave 4!!! #IOLCP

87 - - - >> 110 Breaking out!!! Keep on track!!! #IOLCP

🎙️ IOL Chemicals And Pharmaceuticals (IOLCP) call was streaming live on EquiSense, it just ended. Here is the decode ⬇️ #IOLCP #EarningsCall

#IOLCP- "Metformin is not a differentiated product than rest of the suppliers.Everyone buys DCDA from China & convert it to Metformin & sells" "In Metformin, backward integration is not an option. I will continue to be like every other Metformin player where we all buy DCDA"

#IOLCP List of products APIs in market: Ibuprofen, Metformin, Clopidogrel, Fenofibrate, Lamotrigine & Ursodeoxycholic Acid APIs in the pipeline: Pantoprazole, Gabapentin, Losartan, Domperidone, Fexofenadine, Pregabalin, Quetiapine

#IOLCP - CMP 95 (Holding from 350 before 5:1 split). Added more during the recent fall, around 60 as well. Target 1000+ (You should be patient enough to go through all the zig zags in the coming years) The chart clearly highlights key long-term demand and supply zones. I've compiled some useful data points to support your research. I encourage you to review the information carefully and, if you find it valuable, conduct a thorough analysis and build a strong rationale before considering this stock for the long-term investment.

#AEROFLEX is another instance where open gains vanished in just one go. I had a similar experience with #AARTIPHARM on September 9, then with #IOLCP on September 11, and today it’s #AEROFLEX. Three positions, and the open gains wiped out in a single move. Strange little phase, but it’s part of the game. Got to deal with it and move on.

Strong Breakout Soon Candidate! #IOLCP 1- Mini Basing Pattern 2- Volume Buildup 3- 20-30 EMA Support Keep on Radar. Potential Upside Stock! #stock #trading #investing

#IOLCP : Little bit more Tightness in RHS will make a this a Perfect Setup. Price action is king. Price action will always beat trading indicators. Less indicators, more price action.

💊 IOL Chemicals & Pharmaceuticals | Great #Q2FY27 Results ⏫️ Revenue grew 40.1% YoY to ₹795.03 Cr. ⏫️ Profit before tax surged 115.6% to ₹87.29 Cr. ⏫️ Net profit jumped 117.1% to ₹65.07 Cr. 📈 EPS increased to ₹2.22, from ₹1.02 in Q2 FY26. 💊 Pharmaceuticals revenue grew 40.6% to ₹472.75 Cr. 🧪 Chemicals revenue increased 38.3% to ₹394.49 Cr. 🚀 H1 net profit more than doubled to ₹129.47 Cr, up 102.6% YoY. ⚠️ H1 operating cash flow stood at ₹8.29 Cr, compared with ₹11.06 Cr last year, amid higher working-capital requirements. 💡 Takeaway: Strong earnings growth across both business segments, but cash-flow conversion and working-capital efficiency remain important monitorables. #IOLCP